mydentist Announces Industry-Leading Partnership with vVARDIS – Offering Revolutionary “No Drill” Treatment for Early Tooth Decay

In a first-of-its-kind partnership within UK dentistry, mydentist is set to offer Curodont™ Repair – vVARDIS’ revolutionary drill-free solution for early-stage tooth decay – to its network of over 3,000 dental associates and circa 500 practices across the country.

Recently noted for treating more than two million teeth and over 800,000 patients in the United States since January 20241, vVARDIS is working with mydentist as the first large-scale dental provider partner to offer Curodont™ Repair to patients in the UK.

Using a proprietary biomimetic formulation, Curodont™ Repair is an innovative treatment that is clinically proven to arrest and reverse early tooth decay without the need of a drill. Working together with minerals in the saliva through biomimetic methods, it regenerates the enamel lost in the early stages of tooth decay- helping patients save the natural tooth structure without artificial filling materials.

Up to 80 percent of all dental patients have early tooth decay2. With Curodont™, dental teams have a drill-free solution to treat it at an early stage. Applied by a dentist within ten minutes and with more than 90% efficacy 3,4,5,6, as proven by peer-reviewed publications based on clinical studies, long-term real-world evidence and meta-analyses, Curodont™ Repair represents a true win-win proposition: patients benefit from a quick, needle- and drill-free treatment, while dental professionals can treat early decay within minutes—freeing up chair time for more complex procedures.

With over 4 million patients across the UK, mydentist remains the largest-scale dental provider in the country to offer both NHS and private dental care. Through its new partnership with vVARDIS, it hopes to decrease the amount of tooth decay in the country through offering Curodont™ Repair to patients who are presenting with early signs of caries.

Nyree Whitley, Chief Clinical Officer at mydentist, said: “We know that tooth decay remains one of the top diseases in the world and with cases continuing to rise in the UK, we’re confident that Curodont™ Repair can help us to reduce the number of cases we see every day at mydentist. Through being able to offer this new treatment and working with vVARDIS, we’ll be able to transform the way that we treat our patients. We also know that visiting the dentist to receive treatments such as fillings can cause some anxiety for patients, so through this non-invasive, simple treatment, we’ll also be able to enhance the patient’s experience and hopefully lower their dental anxieties while keeping their oral health in good shape.”

Drs. Haley and Goly Abivardi, founders and co-CEOs of vVARDIS, said: “We are excited to be partnering with mydentist as we continue to expand and grow. Entering into the UK to offer Curodont™ with the country’s leading dental provider will accelerate our ability to serve dental patients and professionals globally and as dentists, we’re delighted to bring a drill-free treatment for early decay that aims to elevate the standard of care for patients around the world.”

Curodont™ Repair will be available across 100 mydentist practices from November and across the whole network from 2026. To book the treatment, patients are encouraged to find and contact their nearest mydentist practice to enquire about Curodont™, if it is available at their practice, the team will be able to advise patients on booking an appointment for an examination with a dentist, who will assess their suitability.

Each course of treatment is competitively priced from £140 and to drive enhanced value to its patients, mydentist will offer one tube of Curodont™ Protect (RRP £20) with every Curodont™ Repair treatment purchased.

Patients can find their nearest mydentist practice via: https://www.mydentist.co.uk/dentists

For further information, please contact Freya Budd, Senior PR Manager at mydentist: fbudd@mydentist.co.uk

mydentist is headquartered in Kearsley, Manchester, and is the UK’s leading provider of affordable dental care, with over 500 practices across the country.

mydentist offers three tiers of affordable dentistry – NHS dental care, myoptions private dental care and Premium private dental care. All three tiers are part of mydentist, and patients can move up and down the tiers as they wish (subject to availability).
Through clear, transparent and fixed pricing structures, mydentist is giving patiens more flexibility and choice when it comes to their dental care.
Led by Chief Executive, Nilesh Pandya, and Executive Chairman Tom Riall, mydentist employs over 7,000 practice and support colleagues and has a network of more than 3,000 dental associates in the UK.
mydentist supports around 4 million patients a year and believes everyone deserves a great smile.

About vVARDIS

vVARDIS is a high-growth healthcare company located in Zug, Switzerland that offers groundbreaking biomimetic, non-invasive solutions for dental professionals under the Curodont™ brand. Founded by Drs. Haley and Goly Abivardi, sisters, Swiss dentists, innovators, and awarded entrepreneurs, vVARDIS is the result of more than 25 years of research, paired with the commitment of its founders to make an impact on people’s lives, especially the underserved.
vVARDIS’ mission is to expand access to novel approaches to the standard of care in dentistry with the purpose of improving oral health – the foundation for overall health. vVARDIS’ technology is backed by more than 25 years of science, 230 scientific publications, including meta-analyses, peer-reviewed clinical studies and a long-term peer-reviewed real-world evidence study demonstrating a success rate above 90 percent. It has been used in clinical practice for more than 10 years and it is already mentioned in lectures at renowned universities as a standard of care for the treatment of early decay. vVARDIS is member of the WEF Innovator Communities.

For more information, visit vVARDIS at www.vVARDIS.com and www.linkedin.com/company/vvardis.

For vVARDIS media inquiries, please contact Gemma Barker, Managing Director at Barker PR, gemma@barkerpr.com

1. Data on file and related to the U.S. product
2. Jacobsen ID et al. Eur ArchPaediatr Dent 2019;20:73-78
3. Bröseler F et al. Clin Oral Investig. 2020; 24:123-132;
4. Welk A et al. Sci Rep 2020; 10:6819;
5. Alkilzy M et al. J Dent Res 2018; 97:148
6. Godenzi D et al. J Am Dent Assoc. 2023:S0002-8177(23)00416-6